India's Mankind Pharma falls on lower quarterly profit

Mankind Pharma

07/11/2025 07:16

**Shares of Mankind Pharma MNKI.NS fall 1.94% to 2264.30 rupees, its lowest since July 1

**Co reports 22% lower quarterly consol net profit of 5.12 billion rupees ($58.25 million); consol revenue from ops falls 20.8% to 36.97 billion rupees

**Co says sales of over-the-counter medication were hurt as distributors delayed purchases ahead of the government's tax cuts, which came into effect on September 22

**Jefferies ("Buy", PT lowered to 3,000 rupees) says co is poised for a recovery from heron as restructuring efforts bear fruit in the core India business

**Stock rated as "Buy" on average by 16 analysts; median PT at 2,780 rupees as per data compiled by LSEG

**YTD, stock down 21.4%

($1 = 87.8950 Indian rupees)

 (Reporting by Mridula Kumar)

 ((Mridula.kumar@thomsonreuters.com))